Lemaitre Vascular, Inc.
A maker of medical devices for vascular surgery, headquartered outside Boston. Its products — including the UniFit graft and Valvulotome — help surgeons treat conditions like peripheral artery disease and maintain dialysis access, used by doctors in hospitals around the world. The company takes its name from its founder, George LeMaitre, a surgeon who built the business around devices he designed for the operating room.
Granted 286.6K · Sold 1.14M
Granted 33.9K
Granted 84.9K · Sold 72.5K
Granted 110.2K · Sold 99.5K
Granted 36.5K · Sold 32.5K
Granted 20.4K · Sold 27.2K
Granted 25.9K · Sold 30.0K
Granted 27.5K · Sold 32.2K
Granted 4.4K · Sold 1.5K
Granted 2.4K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| LeMaitre George WChairman and CEO, Director · 157 transactions | — | 2.93M | 286.6K | — | 1.14M |
| O'Connor John JamesDirector · 32 transactions | +13.8% | 62.8K | 33.9K | — | — |
| Pellegrino Joseph P JRDirector · 90 transactions | +122.3% | 15.0K | 84.9K | — | 72.5K |
| Roberts David BPresident and Director, Director · 107 transactions | +165.6% | 14.7K | 110.2K | — | 99.5K |
| Ross Bridget ADirector · 37 transactions | — | 9.0K | 36.5K | — | 32.5K |
| Jasinski Lawrence JDirector · 38 transactions | -6.5% | 7.8K | 20.4K | — | 27.2K |
| Roush John ADirector · 31 transactions | — | 4.3K | 25.9K | — | 30.0K |
| Kamke Trent GSenior V. P., Operations · 87 transactions | -64.4% | 3.7K | 27.5K | — | 32.2K |
| Shadan MarthaDirector · 22 transactions | — | 3.0K | 4.4K | — | 1.5K |
| LeBlanc Dorian PaulChief Financial Officer · 4 transactions | — | 2.3K | 2.4K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 5 years: -1.43M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.